Status
Conditions
Treatments
About
To externally validate the diagnostic accuracy and assess the clinical utility of a host-response based diagnostic tool called ImmunoXpert™, for differentiating between bacterial and viral etiologies in pediatric patients >3 months old with suspicion of Respiratory tract infection (RTI) or Fever without Source (FWS)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Antibiotic treatment of over 48 hours' duration at time of presentation
Another episode of febrile infection within the past 2 weeks
A proven or suspected HIV1, HBV, or HCV infection
Congenital immune deficiency (CID)
Active malignancy
Current treatment with immune-suppressive or immune-modulating therapies, including without limitations:
Other severe illnesses that affect life expectancy and quality of life such as:
525 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal